Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases certain kidney protein levels, potentially raising blood pressure.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

MC4R gene variants not linked to female hair loss.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

A new gene mutation causes insulin resistance in a girl and her mother.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.